Lifesaving treatment withheld for Livermore amyloidosis patients. Gene silencing infusions for a rare systemic disease called hereditary amyloidosis were withheld. The infusion cancellations were the lone decision of the provider and no alternatives were offered to patients. Even with passage of the Home Infusion Medicare benefit by Congress, patients that requested home infusions have been denied by the provider and consequently suffered injury. For more information go to www.regulations.gov and search for CMS–1744–IFC. Future proof your healthcare.